戻る
10X Genomics Inc (TXG)価格
TXG 株価推移チャート
TXG 収入
10X Genomics Inc
$20.52
-3.2%
$-0.67
終値： Jan 16, 16:00:00 GMT-5
$20.4
-0.58%
$-0.12
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$21.2
始値
$21.21
当日レンジ
$20.39 - $21.35
52週レンジ
$6.78 - $21.5
取引高
1.6M
平均取引高
2.7M
1株当たり利益(TTM)
-0.62
配当利回り
--
時価総額
$2.5B
TXGとは何ですか？
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. The company is headquartered in Pleasanton, California and currently employs 1,306 full-time employees. The company went IPO on 2019-09-12. The firm's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.